115 related articles for article (PubMed ID: 3514913)
1. Substituted isatoic anhydrides: selective inactivators of trypsin-like serine proteases.
Gelb MH; Abeles RH
J Med Chem; 1986 Apr; 29(4):585-9. PubMed ID: 3514913
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based isocoumarin inhibitors for trypsin and blood coagulation serine proteases: new anticoagulants.
Kam CM; Fujikawa K; Powers JC
Biochemistry; 1988 Apr; 27(7):2547-57. PubMed ID: 3164217
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human chymase by 2-amino-3,1-benzoxazin-4-ones.
Neumann U; Schechter NM; Gütschow M
Bioorg Med Chem; 2001 Apr; 9(4):947-54. PubMed ID: 11354678
[TBL] [Abstract][Full Text] [Related]
4. Suicide inactivation of chymotrypsin by benzoxazinones.
Hedstrom L; Moorman AR; Dobbs J; Abeles RH
Biochemistry; 1984 Apr; 23(8):1753-9. PubMed ID: 6562904
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of serine proteases by benzoxazinones: effects of electron withdrawal and 5-substitution.
Spencer RW; Copp LJ; Bonaventura B; Tam TF; Liak TJ; Billedeau RJ; Krantz A
Biochem Biophys Res Commun; 1986 Nov; 140(3):928-33. PubMed ID: 3535800
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory spectrum of mouse contrapsin and alpha-1-antitrypsin against mouse serine proteases.
Takahara H; Sinohara H
J Biochem; 1983 May; 93(5):1411-9. PubMed ID: 6224776
[TBL] [Abstract][Full Text] [Related]
7. Design of alternate substrate inhibitors of serine proteases. Synergistic use of alkyl substitution to impede enzyme-catalyzed deacylation.
Krantz A; Spencer RW; Tam TF; Thomas E; Copp LJ
J Med Chem; 1987 Apr; 30(4):489-91. PubMed ID: 3550086
[No Abstract] [Full Text] [Related]
8. Effect of conformational mobility and hydrogen-bonding interactions on the selectivity of some guanidinoaryl-substituted mechanism-based inhibitors of trypsin-like serine proteases.
Rai R; Katzenellenbogen JA
J Med Chem; 1992 Nov; 35(23):4297-305. PubMed ID: 1447734
[TBL] [Abstract][Full Text] [Related]
9. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.
Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y
J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive study on the mechanism of inhibition of serine proteases by benzamidines based on quantitative structure-activity relationship studies.
Gupta SP; Handa A; Shewade DG
Arzneimittelforschung; 1987 Jan; 37(1):47-50. PubMed ID: 2952126
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of proteases and esterases by halomethylated derivatives of dihydrocoumarins.
Béchet JJ; Dupaix A; Roucous C; Bonamy AM
Biochimie; 1977; 59(3):241-6. PubMed ID: 889930
[TBL] [Abstract][Full Text] [Related]
12. Reaction of serine proteases with substituted 3-alkoxy-4-chloroisocoumarins and 3-alkoxy-7-amino-4-chloroisocoumarins: new reactive mechanism-based inhibitors.
Harper JW; Powers JC
Biochemistry; 1985 Dec; 24(25):7200-13. PubMed ID: 3910097
[TBL] [Abstract][Full Text] [Related]
13. Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity.
Jing H; Babu YS; Moore D; Kilpatrick JM; Liu XY; Volanakis JE; Narayana SV
J Mol Biol; 1998 Oct; 282(5):1061-81. PubMed ID: 9753554
[TBL] [Abstract][Full Text] [Related]
14. 2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease.
Hays SJ; Caprathe BW; Gilmore JL; Amin N; Emmerling MR; Michael W; Nadimpalli R; Nath R; Raser KJ; Stafford D; Watson D; Wang K; Jaen JC
J Med Chem; 1998 Mar; 41(7):1060-7. PubMed ID: 9544206
[TBL] [Abstract][Full Text] [Related]
15. A biotin-conjugated pyridine-based isatoic anhydride, a selective room temperature RNA-acylating agent for the nucleic acid separation.
Ursuegui S; Yougnia R; Moutin S; Burr A; Fossey C; Cailly T; Laayoun A; Laurent A; Fabis F
Org Biomol Chem; 2015 Mar; 13(12):3625-32. PubMed ID: 25671759
[TBL] [Abstract][Full Text] [Related]
16. Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor.
Harper JW; Hemmi K; Powers JC
Biochemistry; 1985 Apr; 24(8):1831-41. PubMed ID: 3893537
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of trypsin-like proteases by sulfonylation. Variation of positively charged group and inhibitor length.
Wong SC; Green GD; Shaw E
J Med Chem; 1978 May; 21(5):456-9. PubMed ID: 660589
[TBL] [Abstract][Full Text] [Related]
18. Tetra-p-amidinophenoxy-propane as a probe of the specificity site of serine proteases.
Menegatti E; Guarneri M; Ferroni R; Bolognesi M; Ascenzi P; Antonini E
FEBS Lett; 1982 May; 141(1):33-6. PubMed ID: 7044822
[No Abstract] [Full Text] [Related]
19. Inhibition of four human serine proteases by substituted benzamidines.
Andrews JM; Roman DP; Bing DH
J Med Chem; 1978 Dec; 21(12):1202-7. PubMed ID: 152812
[TBL] [Abstract][Full Text] [Related]
20. [Synthetic inhibitors targeting serine and aspartic acid proteases].
Reboud-Ravaux MC; Boggetto ND; Doucet CE; de Rosny EH; Vergely IB; Thierry NM; Amour AJ
J Pharm Belg; 1996; 51(3):161-4. PubMed ID: 8778349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
